Explanation for substandard of care comparators in rheumatology randomised trial protocols
Lancet Rheumatol
.
2024 Nov;6(11):e743-e745.
doi: 10.1016/S2665-9913(24)00277-7.
Authors
Jacky Sheng
1
,
Andrew Zhang
1
,
Hannah Moyer
1
,
Marie Hudson
2
,
Glen Hazlewood
3
,
Vibeke Strand
4
,
Jonathan Kimmelman
5
Affiliations
1
Department of Equity, Ethics, and Policy, McGill University, Montreal, QC H3A 1G1, Canada.
2
Department of Medicine, McGill University, Montreal, QC H3A 1G1, Canada; Division of Rheumatology, McGill University, Montreal, QC H3A 1G1, Canada; Lady Davis Institute, McGill University, Montreal, QC H3A 1G1, Canada.
3
Departments of Medicine and Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
4
Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, USA.
5
Department of Equity, Ethics, and Policy, McGill University, Montreal, QC H3A 1G1, Canada. Electronic address: jonathan.kimmelman@mcgill.ca.
PMID:
39443025
DOI:
10.1016/S2665-9913(24)00277-7
No abstract available